How shoddy science is fueling a charge to restrict abortion pill access The FDA has been tasked with re-evaluating the safety of mifepristone after a flawed report claimed it has a high rate of serious complications.

#abortionpillsrestriction #womensreproductiverights @nbcnews.com #MondayMotivation
www.nbcnews.com/health/women...